TScan Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update May 12, 2026
Boehringer Ingelheim licenses preclinical antibody program from Immunitas Therapeutics to advance treatments for chronic inflammatory diseases May 12, 2026
Newleos Announces Dosing of First Participant in Phase 1b Study of NTX-2001 for Alcohol Use Disorder April 29, 2026
Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline April 28, 2026
Avenzo Therapeutics Advances the Combination of CDK4 Selective Inhibitor (AVZO-023) with CDK2 Selective Inhibitor (AVZO-021) in Ongoing Phase 1/2 ORION-1 Study in HR+/HER2- Breast Cancer April 28, 2026
